查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594544

核酸检测市场：按适应症、按产品、按方法、按最终用户 - 2025-2030 年全球预测

Nucleic Acid Testing Market by Indication (Cancer, Forensic Testing, Genetic & Mitochondrial Disorders), Product (Consumables, Nucleic Acid Test Kits), Technique, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

根据预测，2023年核酸检测市场价值为34.3亿美元，预计2024年将达到37.9亿美元，复合年增长率为10.30%，到2030年将达到68.3亿美元。

核酸检测 (NAT) 是分子诊断市场的重要组成部分，能够检测和扩增 DNA 和 RNA 等遗传物质，以识别病原体和异常情况。这项需求源于对准确诊断工具不断增长的需求，特别是考虑到 COVID-19 大流行和感染疾病增加等全球健康挑战。 NAT 的应用领域包括血液筛检、感染疾病诊断和肿瘤学，服务于医疗保健环境、研究机构和生物技术公司。关键的成长要素包括扩增方法的技术进步、医疗保健支出的增加以及早期疾病检测意识的提高。此外，由遗传和基因组资料驱动的个人化医疗正在扩大精准治疗的机会。然而，市场面临着测试成本高、监管障碍以及需要专门的测试基础设施等挑战，这可能会阻碍广泛采用，尤其是在欠发达地区。也就是说，在即时检测创新和开发侵入性较小的样本采集方法方面存在令人兴奋的机会，以促进用户友好和快速的检测解决方案。人工智慧和机器学习与 NAT 的整合还有可能彻底改变资料解释并提高诊断准确性和吞吐量。为了实现业务成长，公司应专注于开发可携式、经济高效的套件，以减少对复杂实验室环境的依赖，这是一个成熟的研究和开发领域。与医疗保健提供者合作以了解他们的具体需求并伙伴关係以扩展到新兴市场可以提高竞争力。随着市场逐渐走向分散式检查环境，提供可扩展和标准化解决方案的能力将变得至关重要。保持领先地位需要持续回应监​​管环境并灵活适应不断发展的技术环境，特别是行动医疗应用的新可能性。

主要市场统计
基准年[2023] 34.3亿美元
预测年份 [2024] 37.9亿美元
预测年份 [2030] 68.3亿美元
复合年增长率（%） 10.30%

市场动态：揭示快速发展的核酸检测市场的关键市场洞察

供需的动态交互作用正在改变核酸检测市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 癌症和其他感染疾病患者增加
    • 人类基因检测的商业化程度提高
    • 流行病防范和消除的需求迅速增加
  • 市场限制因素
    • 庞大的研发成本
  • 市场机会
    • 有吸引力的资金筹措场所和政府支持扩大检测能力
    • 增加政府核准和报销
  • 市场挑战
    • 复杂的设备和技术

波特五力：驾驭核酸检测市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解外部对核酸检测市场的影响

外部宏观环境因素在塑造核酸检测市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解核酸检测市场竞争状况

对核酸检测市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵核酸检测市场厂商绩效评估

FPNV定位矩阵是评估核酸检测市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了核酸检测市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对核酸检测市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 癌症和其他感染疾病的增加
      • 人类基因检测的商业化程度提高
      • 控制和消除疫情的迫切需要
    • 抑制因素
      • 巨额研发投入
    • 机会
      • 有吸引力的资金空间和政府支持扩大检测能力
      • 增加政府核准和报销
    • 任务
      • 复杂的仪器和技术
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 核酸检测市场依适应症分类

  • 癌症
  • 刑事鑑定
  • 遗传和粒线体疾病
  • 感染疾病

第七章 核酸检测市场：副产品

  • 消耗品
  • 核酸检测套组

第八章 核酸检测市场：依技术分类

  • 探针放大系统
  • 讯号放大
  • 目标放大系统

第九章 核酸检测市场：依最终用户分类

  • 医院
  • 病理实验室
  • 调查机构

第十章 南北美洲核酸检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章 亚太地区核酸检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东、非洲核酸检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • 23andMe, Inc.
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • ARUP Laboratories
  • Asuragen Inc.
  • Beckman Coulter, Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomerieux SA
  • Cepheid
  • F. Hoffmann-La Roche Ltd.
  • Gen-Probe, Inc.
  • Illumina, Inc.
  • Novartis AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-036C5CF3B554

The Nucleic Acid Testing Market was valued at USD 3.43 billion in 2023, expected to reach USD 3.79 billion in 2024, and is projected to grow at a CAGR of 10.30%, to USD 6.83 billion by 2030.

Nucleic Acid Testing (NAT) represents a significant segment within the molecular diagnostics market, equipped to detect and amplify genetic material like DNA and RNA to identify pathogens or anomalies. Its necessity stems from the growing demand for accurate diagnostic tools, especially in light of global health challenges such as the COVID-19 pandemic and rising incidences of infectious diseases. NAT's applications span across diverse segments including blood screening, infectious disease diagnosis, and oncology, serving healthcare settings, research institutions, and biotechnology firms. Key growth factors include technological advancements in amplification methods, increased healthcare expenditures, and heightened awareness of early disease detection. Moreover, personalization in medicine, driven by genetic and genomic data, opens opportunities in precision therapies. However, the market faces challenges such as high test costs, regulatory hurdles, and the requirement for specialized laboratory infrastructure, which could hamper widespread adoption, especially in underdeveloped regions. Nevertheless, exciting opportunities lie in point-of-care testing innovations and the development of less invasive sample collection methods, fostering user-friendly and rapid testing solutions. The integration of AI and machine learning with NAT could also revolutionize data interpretation, enhancing diagnostic accuracy and throughput. For business growth, companies should focus on developing portable, cost-effective nucleic acid testing kits that reduce dependency on complex lab settings, an area ripe for research and development. Collaborations with healthcare providers to understand specific needs and partnerships for expanding into emerging markets can provide a competitive edge. As the market gradually transitions towards decentralized testing environments, the ability to offer scalable and standardized solutions will be crucial. To stay ahead, continuous focus on regulatory compliance and agile adaptation to evolving technological landscapes will be necessary, especially concerning emerging potential for mobile health applications.

KEY MARKET STATISTICS
Base Year [2023] USD 3.43 billion
Estimated Year [2024] USD 3.79 billion
Forecast Year [2030] USD 6.83 billion
CAGR (%) 10.30%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Nucleic Acid Testing Market

The Nucleic Acid Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising cases of cancer and other infectious diseases
    • Increased commercialization of human genetic tests
    • Exponential need in pandemic control and eradication
  • Market Restraints
    • Huge expenditure on R&D
  • Market Opportunities
    • Attractive funding space and government support to expand testing capabilities
    • Increasing government approvals and reimbursements available
  • Market Challenges
    • Complex instrumentation and technology

Porter's Five Forces: A Strategic Tool for Navigating the Nucleic Acid Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Nucleic Acid Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Nucleic Acid Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Nucleic Acid Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Nucleic Acid Testing Market

A detailed market share analysis in the Nucleic Acid Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Nucleic Acid Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Nucleic Acid Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Nucleic Acid Testing Market

A strategic analysis of the Nucleic Acid Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Nucleic Acid Testing Market, highlighting leading vendors and their innovative profiles. These include 23andMe, Inc., Abbott Laboratories, Agilent Technologies, Inc., ARUP Laboratories, Asuragen Inc., Beckman Coulter, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Biomerieux SA, Cepheid, F. Hoffmann-La Roche Ltd., Gen-Probe, Inc., Illumina, Inc., Novartis AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Nucleic Acid Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Indication, market is studied across Cancer, Forensic Testing, Genetic & Mitochondrial Disorders, and Infectious Disease.
  • Based on Product, market is studied across Consumables and Nucleic Acid Test Kits.
  • Based on Technique, market is studied across Probe Amplification Systems, Signal Amplification, and Target Amplification Systems.
  • Based on End User, market is studied across Hospitals, Pathology Laboratories, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising cases of cancer and other infectious diseases
      • 5.1.1.2. Increased commercialization of human genetic tests
      • 5.1.1.3. Exponential need in pandemic control and eradication
    • 5.1.2. Restraints
      • 5.1.2.1. Huge expenditure on R&D
    • 5.1.3. Opportunities
      • 5.1.3.1. Attractive funding space and government support to expand testing capabilities
      • 5.1.3.2. Increasing government approvals and reimbursements available
    • 5.1.4. Challenges
      • 5.1.4.1. Complex instrumentation and technology
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Nucleic Acid Testing Market, by Indication

  • 6.1. Introduction
  • 6.2. Cancer
  • 6.3. Forensic Testing
  • 6.4. Genetic & Mitochondrial Disorders
  • 6.5. Infectious Disease

7. Nucleic Acid Testing Market, by Product

  • 7.1. Introduction
  • 7.2. Consumables
  • 7.3. Nucleic Acid Test Kits

8. Nucleic Acid Testing Market, by Technique

  • 8.1. Introduction
  • 8.2. Probe Amplification Systems
  • 8.3. Signal Amplification
  • 8.4. Target Amplification Systems

9. Nucleic Acid Testing Market, by End User

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Pathology Laboratories
  • 9.4. Research Institutes

10. Americas Nucleic Acid Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Nucleic Acid Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Nucleic Acid Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 23andMe, Inc.
  • 2. Abbott Laboratories
  • 3. Agilent Technologies, Inc.
  • 4. ARUP Laboratories
  • 5. Asuragen Inc.
  • 6. Beckman Coulter, Inc.
  • 7. Becton Dickinson and Company
  • 8. Bio-Rad Laboratories, Inc.
  • 9. Biomerieux SA
  • 10. Cepheid
  • 11. F. Hoffmann-La Roche Ltd.
  • 12. Gen-Probe, Inc.
  • 13. Illumina, Inc.
  • 14. Novartis AG
  • 15. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. NUCLEIC ACID TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. NUCLEIC ACID TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. NUCLEIC ACID TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. NUCLEIC ACID TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NUCLEIC ACID TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NUCLEIC ACID TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY FORENSIC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY GENETIC & MITOCHONDRIAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY NUCLEIC ACID TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PROBE AMPLIFICATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY SIGNAL AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TARGET AMPLIFICATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PATHOLOGY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. NUCLEIC ACID TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. NUCLEIC ACID TESTING MARKET, FPNV POSITIONING MATRIX, 2023